| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BriaCell Therapeutics (NASDAQ:BCTX) through any online brokerage.
Other companies in BriaCell Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BriaCell Therapeutics has a consensus price target of $40.00.
The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $4.1396 last updated October 6, 2026 at 8:22 AM EDT.
There are no upcoming dividends for BriaCell Therapeutics.
BriaCell Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for BriaCell Therapeutics.
BriaCell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
